• Explore /
  • Poster
  • / Testing patterns and prevalence of <em>PIK3CA</em>, <em>AKT1</em>, and <em>PTEN</em> alterations among patients (pts) with HR+/HER2- metastatic breast cancer (mBC) in the US.

Testing patterns and prevalence of PIK3CA, AKT1, and PTEN alterations among patients (pts) with HR+/HER2- metastatic breast cancer (mBC) in the US.

Abstract Poster

Authors

null

Leah Park

AstraZeneca, Gaithersburg, MD

Leah Park , Samantha L Thompson , James Roose , Yichen Lu , Moumita Chaki , Clara Lam , Bryan Iorgulescu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Biologic Correlates

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 1041)

DOI

10.1200/JCO.2024.42.16_suppl.1041

Abstract #

1041

Poster Bd #

19

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Quality Care Symposium

Innovative biomarker testing initiative in a community oncology setting.

Innovative biomarker testing initiative in a community oncology setting.

First Author: Lorraine Brisbin

First Author: Mehreen Aftab

First Author: Sherry Shen

First Author: Mohammad Arfat Ganiyani